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M. ulcerans is known to be asso-
ciated with wetlands, and the Kouilou 
River environment is certainly suitable 
for its spread (10). Identification of this 
zone as a high-risk area for Buruli ulcer 
disease will help the Ministry of Health 
improve early detection, biological 
confirmation, and treatment programs. 
In the other regions, active and contin-
uous surveillance is necessary to estab-
lish a detailed map of the villages and 
areas where Buruli ulcer disease is en-
demic; such information would enable 
the implementation of targeted control 
activities. However, active surveillance 
in Congo has substantially declined 
since 2011. Our findings support the 
reactivation of such surveillance cam-
paigns to ensure the early identification 
and confirmation of Buruli ulcer cases 
and to improve patient management.
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Rapid Metagenomic 
Diagnostics for  
Suspected  
Outbreak of  
Severe Pneumonia
To the Editor: Recent outbreaks 
of severe pneumonia or acute respira-
tory distress syndrome (ARDS) have 
attracted much public interest. Given 
current awareness levels, clinical per-
sonnel and health officials must rapid-
ly and adequately respond to suspected 
outbreaks to prevent public disturbanc-
es. We report a case that highlights the 
potential of next-generation sequenc-
ing (NGS) to complement convention-
al diagnostics in such scenarios.
On March 29, 2013, a police of-
ficer (patient 1) was admitted to the 
emergency department of the Univer-
sity Medical Centre Hamburg–Eppen-
dorf in Hamburg, Germany, because 
of ARDS. The patient was given me-
chanical ventilation; all diagnostic 
test results for pathogens commonly 
known to cause pneumonia were 
negative (www.virus-genomics.org/
supplementaries/EID1406.pdf). Al-
though treatment with antimicrobial 
drugs was immediately initiated, the 
patient died 6 days later of multiple 
organ failure.
On April 5, a second police offi-
cer (patient 2) from the same county 
was admitted to the same emergency 
department because of ARDS. He 
was transferred to the intensive care 
unit and given mechanical ventilation. 
Similar to the situation for patient 1, 
diagnostic test results were negative, 
prompting the news media to suspect 
an outbreak of a novel or mutated 
virus (1,2). Especially because of si-
multaneous outbreaks of avian influ-
enza and infections with Middle East 
respiratory syndrome coronavirus in 
other parts of the world, these reports 
caused serious concern among the 
public and health officials.
After the death of patient 1 and hos-
pitalization of patient 2, we subjected 
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Figure.	Next-generation	sequencing	of	RNA	(RNaseq)	and	DNA	(DNaseq)	isolated	from	bronchoalveolar	lavage	(BAL)	samples	from	3	
patients	with	severe	pneumonia,	northern	Germany.	Shown	are	data	from	BLASTN	(http://blast.ncbi.nlm.nih.gov/Blast.cgi)	analysis	of	de	
novo	assembled	sequence	contigs	(www.virus-genomics.org/supplementals/EID1406.pdf).	Relative	abundance	of	contig	reads	mapping	
bacterial,	fungal,	or	viral	species	is	indicated	by	a	heat	map	(scale	bar).	White	areas	indicate	that	no	reads	were	detected.	Diagnostic	
samples	were	obtained	from	3	patients	(lanes	P1,	P2,	and	P3).	Lane	B,	control	BAL	sample	(analyzed	by	using	RNaseq	only)	from	an	
influenza	patient;	 lane	1,	MS:	analysis	 on	 the	 Illumina	MiSeq	platform	 (www.illumina.com/systems.ilmn);	 lane	2,	HS:	analysis	 on	 the	
Illumina	HiSeq	platform	(www.illumina.com/systems.ilmn);	lane	3,	HS	dpl.,	RNA	samples	depleted	of	human	rRNA	before	analysis	on	an	
HiSeq	instrument.	Chlamydophila psittaci,	which	was	unequivocally	detected	in	all	samples	from	patient	2	but	not	in	samples	from	the	
other	patients,	is	indicated	by	an	arrow.	Symb.,	symbiont;	Uncult.,	uncultured;	Unclsfd.,	unclassified;	SEN	virus,	strain	of	Torque	teno	virus.	
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nucleic acids extracted from bron-
choalveolar lavage (BAL) specimens 
from both patients to NGS by using a 
MiSeq sequencer (www.illumina.com/
systems.ilmn). To enable rapid and un-
biased detection of bacterial and viral 
agents, we did not enrich specific se-
quences. The entire workflow (www.
virus-genomics.org/supplementaries/
EID1406.pdf) was completed within 
50 hours.
First-line analysis clearly iden-
tified Chlamydophila psittaci in the 
RNA sample from patient 2, but no se-
quences of obvious pathogenic origin 
were detected in samples from patient 
1 (Figure). C. psittaci, an intracellular 
bacterium, can be transmitted by in-
haling aerosolized secretions or feces 
from infected birds (3). Person-to-
person transmission of this bacterium 
is rare (4,5). Ornithosis, a disease char-
acterized by severe pneumonia and in-
fluenza-like symptoms, might develop 
in persons infected with this bacterium. 
Because of the rarity of the disease, 
standard diagnostic panels usually do 
not include C. psittaci. After 11 days of 
antimicrobial drug treatment, the con-
dition of patient 2 improved, and the 
patient was transferred to a general 
hospital ward.
On April 29, a third police officer 
(patient 3) who had been sharing office 
space with patient 2, came to the hospi-
tal with symptoms of pneumonia. After 
antimicrobial drug treatment, his con-
dition rapidly improved and the patient 
was discharged on day 7.
At admission of patient 3, sam-
ples from all 3 patients were analyzed 
at greater read depth by using a HiSeq 
system. RNA sequencing identified 
commensal bacteria in all samples, 
but C. psittaci was present only in 
samples from patient 2 (Figure). 
Likewise, subsequent high-through-
put 16S rRNA sequencing (6), PCR, 
and serologic analysis unequivocally 
identified a C. psittaci infection in pa-
tient 2, but not in patients 1 or 3 (www.
virus-genomics.org/supplementaries/
EID1406.pdf).
We did not detect viral patho-
gens in any samples. At the DNA 
level, most nonhost reads originated 
from nonpathogenic single-stranded 
DNA anelloviruses (7). No RNA vi-
ruses were found, although influenza 
A(H3N2) virus was readily identified 
in a MiSeq analysis of a control BAL 
sample from a patient with a diagnosis 
of influenza A (PCR cycle threshold 
32) (Figure). Furthermore, pairwise 
BLAST analysis (http://blast.ncbi.nlm.
nih.gov/Blast.cgi) did not reveal the 
presence of unknown sequence contigs 
that were shared among the patients, 
as would be expected in case of infec-
tion with a novel viral agent. Together 
with the confirmed C. psittaci infection 
in patient 2, the absence of a common 
pathogen signature strongly suggests 
that the cases were unrelated.
We used a comprehensive metage-
nomic approach to resolve cases sus-
pected of representing an ongoing 
outbreak. The method used enabled 
diagnosis of a C. psittaci infection 
within a reasonable timeframe to allow 
for timely clinical intervention. These 
findings strongly suggest that NGS 
methods can complement conventional 
diagnostics (8–10) and also highlight 
their potential to aid clinical person-
nel and health agencies in making ap-
propriate decisions during suspected 
outbreaks. Clearly, however, NGS-
based methods will have to be further 
standardized and validated before their 
full potential in diagnostic settings can 
be realized.
The absence of pathogenic se-
quences in patients 1 and 3 might 
suggest that their clinical symptoms 
had noninfectious causes. However, 
although samples were collected dur-
ing the acute phase of clinical symp-
toms, and despite our ability to detect 
an influenza A infection in controls, 
we cannot fully exclude the possibil-
ity that a potentially causative patho-
gen present at low levels might have 
evaded detection. Thus, systematic 
and correlative studies evaluating the 
sensitivity of NGS-based detection 
methods in different diagnostic enti-
ties are urgently needed.
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Respiratory  
Infection with  
Enterovirus  
Genotype C117, 
China and Mongolia
To the Editor: Enteroviruses 
(EVs) are small, nonenveloped vi-
ruses of the family Picornaviridae (1). 
EVs are classified into 12 species ac-
cording to the molecular and antigenic 
properties of their viral capsid protein 
(VP1). To date, 7 species are known 
to infect humans, including EV-A 
to EV-D and rhinovirus A, B, and C 
(www.picornastudygroup.com/taxa/
species/species.htm)
EV-C117 was a newly found 
EV-C genotype. It was identified in 
a nasopharyngeal sample from a hos-
pitalized child, 3 years and 9 months 
of age, with community-acquired 
pneumonia in Lithuania in 2012 (2,3). 
However, aside from this case, little is 
known about the prevalence and clini-
cal significance of EV-C117. Here, we 
report the detection of EV-C117 in 
children in China and Mongolia with 
respiratory tract infections (RTIs).
During March 2007–March 2013, 
we screened for EV-C117 in respira-
tory samples from patients with RTIs 
in China and Mongolia, including 
nasopharyngeal aspirates collected 
from 3,108 children in China who 
had lower respiratory tract infections 
when they were admitted to Beijing 
Children’s Hospital (4) and swab sam-
ples from 2,516 patients in Mongo-
lia with influenza-like illness (online 
Technical Appendix Table 1, wwwnc.
cdc.gov/EID/article/20/6/13-1596-
Techapp1.pdf). Respiratory viruses in 
samples from China were screened by 
using multiplex PCR and single PCR 
assays as described (4). Samples from 
Mongolia were screened by using the 
FTD Respiratory Pathogens Multiplex 
Assay Kit (Fast-track Diagnostics, 
Luxembourg City, Luxembourg). EV-
positive samples were further geno-
typed by using reverse transcription 
PCR (RT-PCR) and primers sequen-
tially targeting the VP1 region (5), the 
5′-untranslated region (5′-UTR)/VP4/
VP2 region (6) and the 5′-UTR (7). 
A 394-nt amplicon corresponding to 
the 5′-UTR of EVs was obtained from 
10 children in China; a 598-nt am-
plicon corresponding to the 5′-UTR/
VP4/VP2 region was obtained by 
RT-PCR from 5 children in Mongo-
lia. Blastn analysis (www.blast.ncbi.
nlm.nih.gov/Blast.cgi) of PCR am-
plicons showed that only amplicons 
detected in 2 children from China 
(patients BCH096A and BCH104A) 
and 2 children from Mongolia (pa-
tients MGL126 and MGL208) had the 
highest similarity (95%–98%) to the 
EV-C117 prototype strain LIT22.
To further confirm that these 4 
strains belong to EV-C117, we at-
tempted to amplify the full-length viral 
genome sequences. However, we only 
obtained full-length viral genome se-
quences from the 2 strains found in pa-
tients from China (GenBank accession 
nos. JX560527 [patient BCH096A], 
and JX560528 [patient BCH104A], 
respectively). For the remaining 2 
strains from Mongolia, MGL126 
(5′UTR/VP4/VP2: KF726102; VP1: 
KF726100) and MGL208 (5′UTR/VP4/
VP2: KF726103; VP1: KF726101), we 
obtained the sequence of the 5′-UTR/
VP4/VP2 region and VP1 gene. Phy-
logenetic analysis of these sequenc-
es showed that they all belonged to 
genotype EV-C117 (Figure, panels A 
and B).
Virus isolation for EV-C117 
by using Vero and H1-HeLa cells 
was unsuccessful. Through blastn 
and phylogenetic analyses, we also 
found that the previously identified 
EV-C strain HC90835 (EU697831, 
from Nepal) (8), EV-C104 strain CL-
C22 (EU840734, EU840744, and 
EU840749, from Switzerland) (9) 
and a rhinovirus strain SE-10–028 
(JQ417886, from South Korea), also 
belong to EV-C117 (Figure, panel 
A), indicating that EV-C117 is widely 
distributed geographically. Because a 
large proportion of EV infections are 
subclinical or mild (1), the prevalence 
of EV-C117 should be further estimat-
ed by using serologic investigations in 
general populations.
The VP1 sequences of the EV-
C117 strains isolated in China and 
Mongolia were 89.9%–95.6% (nt) and 
95.2%–98.3% (aa) identical to the EV-
C117 prototype strain LIT22 (patient 
JX262382). Alignment analysis of 
amino acid sequences showed differ-
ences between strains isolated in this 
study and LIT22, i.e., Ser15 (strains 
